Sponsor content
270 result(s) found, displaying 91 to 100
-
Cancellation by sponsorRequested by Janssen-Cilag Pty Ltd
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Esketamine hydrochloride
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Guselkumab
-
Prescription medicine decision summaryTGA decision: Spravato (esketamine hydrochloride) is approved for the treatment of treatment resistant depression.
-
Prescription medicine registrationActive ingredients: esketamine hydrochloride.
-
-
-
-
Cancellation by sponsorRequested by Janssen-Cilag Pty Ltd
-
Cancellation by sponsorRequested by Janssen-Cilag Pty Ltd